ReviewFrontiers in oncology2026
Research trends in depression associated with gynecologic cancers from 2006 to 2025: a multidatabase bibliometric and visual analysis.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gynecologic malignancies are an important cause of illness among women. Depressive symptoms are common throughout diagnosis, treatment, and survivorship. However, bibliometric evidence concerning this topic remains scarce. This bibliometric analysis characterizes research trends and identifies major research hotspots in the literature on depression associated with gynecologic cancer, thereby informing future research and clinical practice. Methods: Relevant publications issued from January 1, 2006, to December 31, 2025, were identified through WOSCC, PubMed, and Scopus. The records were examined and mapped with VOSviewer, CiteSpace, and bibliometrix. Results: The final analysis comprised 734 publications. Research output on depression in patients with gynecologic cancer generally increased from 2006 to 2025. The USA accounted for the greatest share of the literature, and the University of Texas MD Anderson Cancer Center contributed the most papers among institutions. Sood, Anil K. had the most prolific author, whereas the publications by Lutgendorf, Susan K. had the highest average citation count. Among the journals analyzed, Conclusions: Depression associated with gynecologic cancers has received increasing attention, with growing emphasis on patients' quality of life. Future research may increasingly focus on the treatment and supportive care of depression in patients with gynecologic cancers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.